Do we have enough evidence for expanding the indications of ESD for EGC?

Hang Lak Lee, Chang Hwan Choi, Dae Young Cheung

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Endoscopic submucosal dissection (ESD) is the most advanced and representative technique in the field of therapeutic endoscopy and has been used for the treatment of gastrointestinal neoplasms, including early gastric cancer. The major difference and advantage of ESD compared to existing endoscopic resection techniques, such as endoscopic mucosal resection (EMR) and polypectomy, are the width and depth of the resection. Newly developed cutting devices, distal attachable endoscopic accessories, and an advanced electrosurgical unit have helped to overcome the limitations of therapeutic endoscopy in terms of lesion size, location, presence of fibrotic scarring, and accompanying ulcers. As a result, the indications for ESD have been expanded from the classical indication for EMR and polypectomy, and there is now support for a further expansion of ESD indications. At present, the most critical factor to consider in the decision of whether to perform ESD is the probability of unexpected lymph node metastasis. The guidelines for ESD are continually being updated and debated. In this review, we discuss the strengths and weaknesses of the expanded guidelines, based on evidence found in the literature.

Original languageEnglish
Pages (from-to)2597-2601
Number of pages5
JournalWorld Journal of Gastroenterology
Volume17
Issue number21
DOIs
StatePublished - 2011 Jun 7

Fingerprint

Endoscopy
Guidelines
Gastrointestinal Neoplasms
Endoscopic Mucosal Resection
Ulcer
Stomach Neoplasms
Cicatrix
Lymph Nodes
Neoplasm Metastasis
Equipment and Supplies
Therapeutics

Keywords

  • Early gastric cancer
  • Endoscopic mucosal resection
  • Endoscopic submucosal dissection
  • Indications

Cite this

Lee, Hang Lak ; Choi, Chang Hwan ; Cheung, Dae Young. / Do we have enough evidence for expanding the indications of ESD for EGC?. In: World Journal of Gastroenterology. 2011 ; Vol. 17, No. 21. pp. 2597-2601.
@article{fda90b1c28ca48c599229b2845120a51,
title = "Do we have enough evidence for expanding the indications of ESD for EGC?",
abstract = "Endoscopic submucosal dissection (ESD) is the most advanced and representative technique in the field of therapeutic endoscopy and has been used for the treatment of gastrointestinal neoplasms, including early gastric cancer. The major difference and advantage of ESD compared to existing endoscopic resection techniques, such as endoscopic mucosal resection (EMR) and polypectomy, are the width and depth of the resection. Newly developed cutting devices, distal attachable endoscopic accessories, and an advanced electrosurgical unit have helped to overcome the limitations of therapeutic endoscopy in terms of lesion size, location, presence of fibrotic scarring, and accompanying ulcers. As a result, the indications for ESD have been expanded from the classical indication for EMR and polypectomy, and there is now support for a further expansion of ESD indications. At present, the most critical factor to consider in the decision of whether to perform ESD is the probability of unexpected lymph node metastasis. The guidelines for ESD are continually being updated and debated. In this review, we discuss the strengths and weaknesses of the expanded guidelines, based on evidence found in the literature.",
keywords = "Early gastric cancer, Endoscopic mucosal resection, Endoscopic submucosal dissection, Indications",
author = "Lee, {Hang Lak} and Choi, {Chang Hwan} and Cheung, {Dae Young}",
year = "2011",
month = "6",
day = "7",
doi = "10.3748/wjg.v17.i21.2597",
language = "English",
volume = "17",
pages = "2597--2601",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
number = "21",

}

Do we have enough evidence for expanding the indications of ESD for EGC? / Lee, Hang Lak; Choi, Chang Hwan; Cheung, Dae Young.

In: World Journal of Gastroenterology, Vol. 17, No. 21, 07.06.2011, p. 2597-2601.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Do we have enough evidence for expanding the indications of ESD for EGC?

AU - Lee, Hang Lak

AU - Choi, Chang Hwan

AU - Cheung, Dae Young

PY - 2011/6/7

Y1 - 2011/6/7

N2 - Endoscopic submucosal dissection (ESD) is the most advanced and representative technique in the field of therapeutic endoscopy and has been used for the treatment of gastrointestinal neoplasms, including early gastric cancer. The major difference and advantage of ESD compared to existing endoscopic resection techniques, such as endoscopic mucosal resection (EMR) and polypectomy, are the width and depth of the resection. Newly developed cutting devices, distal attachable endoscopic accessories, and an advanced electrosurgical unit have helped to overcome the limitations of therapeutic endoscopy in terms of lesion size, location, presence of fibrotic scarring, and accompanying ulcers. As a result, the indications for ESD have been expanded from the classical indication for EMR and polypectomy, and there is now support for a further expansion of ESD indications. At present, the most critical factor to consider in the decision of whether to perform ESD is the probability of unexpected lymph node metastasis. The guidelines for ESD are continually being updated and debated. In this review, we discuss the strengths and weaknesses of the expanded guidelines, based on evidence found in the literature.

AB - Endoscopic submucosal dissection (ESD) is the most advanced and representative technique in the field of therapeutic endoscopy and has been used for the treatment of gastrointestinal neoplasms, including early gastric cancer. The major difference and advantage of ESD compared to existing endoscopic resection techniques, such as endoscopic mucosal resection (EMR) and polypectomy, are the width and depth of the resection. Newly developed cutting devices, distal attachable endoscopic accessories, and an advanced electrosurgical unit have helped to overcome the limitations of therapeutic endoscopy in terms of lesion size, location, presence of fibrotic scarring, and accompanying ulcers. As a result, the indications for ESD have been expanded from the classical indication for EMR and polypectomy, and there is now support for a further expansion of ESD indications. At present, the most critical factor to consider in the decision of whether to perform ESD is the probability of unexpected lymph node metastasis. The guidelines for ESD are continually being updated and debated. In this review, we discuss the strengths and weaknesses of the expanded guidelines, based on evidence found in the literature.

KW - Early gastric cancer

KW - Endoscopic mucosal resection

KW - Endoscopic submucosal dissection

KW - Indications

UR - http://www.scopus.com/inward/record.url?scp=79958072601&partnerID=8YFLogxK

U2 - 10.3748/wjg.v17.i21.2597

DO - 10.3748/wjg.v17.i21.2597

M3 - Review article

C2 - 21677826

AN - SCOPUS:79958072601

VL - 17

SP - 2597

EP - 2601

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 21

ER -